RNS Number : 0435T
San Leon Energy PLC
20 July 2022
 

 

 

20 July 2022

San Leon Energy plc

("San Leon" or the "Company")

 

Execution of New ELI Investments documentation

 

San Leon, the independent oil and gas production, development and exploration company focused on Nigeria announces that, further to the Company's AIM Admission Document published on 8 July 2022 (the "Admission Document"), the documents in respect of the New ELI Investment have now been signed by the relevant parties, being ELI Malta and San Leon Energy Financing.

 

The New ELI Investment comprises of:

(i)    the New ELI Loan from San Leon to ELI of US$16,000,000 at a coupon of 14% per annum over four years and repayable quarterly following a one-year moratorium; and

(ii)   the New ELI Subscription at nominal value of a further 10 per cent. of ELI's diluted share capital.

 

Details of the New ELI Investment, which remains conditional, amongst other things, on San Leon shareholder approval at the EGM convened for 5 August 2022, were announced by the Company on 8 July 2022 and can be found in the Admission Document which is available on the Company's website: https://www.sanleonenergy.com.

 

Unless otherwise defined herein, the capitalised defined terms used in this announcement have the same meaning as those used in the Admission Document.

 

 

Enquiries:

San Leon Energy plc

+353 1291 6292

Oisin Fanning, Chief Executive

Julian Tedder, Chief Financial Officer

 

Allenby Capital Limited

(Nominated adviser and joint broker to the Company)

+44 20 3328 5656

Nick Naylor

Alex Brearley

Vivek Bhardwaj

 

Panmure Gordon & Co

(Joint broker to the Company)

+44 20 7886 2500

Nick Lovering

James Sinclair-Ford

 

Tavistock

(Financial Public Relations)

+44 20 7920 3150

Nick Elwes

Simon Hudson

 

Plunkett Public Relations

+353 1 230 3781

Sharon Plunkett

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDVKLFFLDLBBBF